1. Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
   Milene Volpato et al, 2020, Exploration of Targeted Anti-tumor Therapy CrossRef
2. Effects of MiR-27a on proliferation and apoptosis of breast cancer cells by targeting KRAS
   Xinzhou BAO et al, 2023, Minerva Medica CrossRef
3. COMPARATIVE ANALYSIS OF THE EXOSOMAL CARGO OF THE ESTROGEN-RESISTANT BREAST CANCER CELLS
   S. E. Semina et al, 2018, Siberian journal of oncology CrossRef
4. MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
   Jingcheng Zhang et al, 2019, Frontiers in Oncology CrossRef
5. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
   Jin-hai Tian et al, 2021, Frontiers in Oncology CrossRef
6. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer
   Elena-Georgiana Dobre et al, 2020, Cancers CrossRef
7. From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
   Jéssica Fernanda Barazetti et al, 2021, Cancers CrossRef
8. miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
   Erik Kudela et al, 2020, International Journal of Molecular Sciences CrossRef
9. Dual-Channel Heterogeneous Graph Neural Network for Predicting microRNA-Mediated Drug Sensitivity
   Lei Deng et al, 2022, Journal of Chemical Information and Modeling CrossRef
10. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
    Nina Petrović et al, 2021, Journal of Mammary Gland Biology and Neoplasia CrossRef